XANAX

This brand name is authorized in United States. It is also authorized in Canada, Croatia, Cyprus, Ecuador, Estonia, France, Hong Kong SAR China, Ireland, Israel, Lithuania, Malta, Netherlands, Poland, Romania, Singapore, Tunisia, Turkey, UK.

Active ingredients

The drug XANAX contains one active pharmaceutical ingredient (API):

1	Alprazolam UNII YU55MQ3IZY - ALPRAZOLAM
	Alprazolam, like other benzodiazepines, has a high affinity for the benzodiazepine binding site in the brain. It facilitates the inhibitory neurotransmitter action of gamma-aminobutyric acid, which mediates both pre- and post synaptic inhibition in the central nervous system (CNS).
	Read more about Alprazolam

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
XANAX Tablet	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N05BA12	Alprazolam	N Nervous system → N05 Psycholeptics → N05B Anxiolytics → N05BA Benzodiazepine derivatives
Discover more medicines within N05BA12

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	00548359, 00548367, 00723770, 00813958
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	591-MEE-0115, 595-MEE-0115, 767-MEE-0215
EE	Ravimiamet	1021835, 1021846, 1021857, 1021868, 1021880, 1021891, 1126673, 1138564, 1138575, 1766202, 1850071, 1850082, 1850093, 1850105, 1865820
FR	Base de données publique des médicaments	60647049, 69847791
GB	Medicines & Healthcare Products Regulatory Agency	46586, 46595
HK	Department of Health Drug Office	17668, 17669
HR	Agencija za lijekove i medicinske proizvode	HR-H-020745058, HR-H-204001816, HR-H-365377512, HR-H-466930724
IE	Health Products Regulatory Authority	53929, 53996, 54003
IL	מִשְׂרַד הַבְּרִיאוּת	4307, 4308, 4309
LT	Valstybinė vaistų kontrolės tarnyba	1007888, 1007889, 1007890, 1008129, 1008130, 1008131, 1009106, 1009107, 1066136, 1066137, 1069228, 1069229, 1069230, 1069231, 1069232, 1069233, 1069234, 1069235, 1078460, 1078461, 1081769, 1081770, 1081771, 1091680, 1091681, 1091682, 1091683, 1092144, 1092145, 1092146
MT	Medicines Authority	MA1396/01201, MA1396/01202, PI1438/04001A, PI1438/04001B, PI1438/04002A, PI1438/04002B, PI242/01301A, PI242/01302A
NL	Z-Index G-Standaard, PRK	49581, 49603, 49611
PL	Rejestru Produktów Leczniczych	100000936, 100071994, 100072002, 100072019, 100083626, 100193415, 100247022, 100267600, 100267639, 100267645, 100270937, 100270943, 100270950, 100271090, 100271747, 100271836, 100271842, 100272570, 100272586, 100272876, 100272882, 100346971, 100350352, 100350375, 100350381, 100358193, 100358709, 100363290, 100363751, 100365939, 100381051, 100388917, 100389740, 100396756, 100398206, 100398324, 100399619, 100399631, 100401606, 100401629, 100401635, 100402043, 100404935, 100406294, 100406319, 100407359, 100408809, 100412403, 100412478, 100412490, 100413331, 100413348, 100413609, 100423980, 100424079, 100424174, 100426055, 100427511, 100428893, 100429527, 100429533, 100429639, 100429668, 100429792, 100442077, 100443616, 100443622, 100454437, 100455583, 100455817, 100455824, 100467109
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W67287001, W67288001, W67289001, W67290001
SG	Health Sciences Authority	01710P, 01984P, 01985P, 07126P, 09173P, 09174P, 09175P, 09176P
TN	Direction de la Pharmacie et du Médicament	25903011, 25903012, 25903013, 8013041, 8013044
TR	İlaç ve Tıbbi Cihaz Kurumu	8699532014184, 8699532014504, 8699532014566, 8699532017802, 8699532017819
US	FDA, National Drug Code	0009-0029, 0009-0055, 0009-0057, 0009-0059, 0009-0066, 0009-0068, 0009-0090, 0009-0094